Speaker Profile
Ph.D., CEO & Co-founder, Resero Bio
Biography
Monica is advancing cfRNA-based liquid biopsy from research into the clinic. Monica developed Resero’s foundational RARE-seq technology during her doctoral training at Stanford with her co-founders, liquid biopsy pioneers Max Diehn and Ash Alizadeh, and is first author of the 2025 Nature paper describing the platform. She now leads the company’s strategic development, partnerships, and fundraising, and is building its first clinical test, a urine-based assay for bladder cancer detection and monitoring. She previously was an early employee at cancer genomics start-up Personal Genome Diagnostics and studied biomedical engineering at Harvard.
Talk
Resero Bio: Unlocking the Cell-Free Transcriptome
Resero Bio’s RARE-seq platform measures gene expression non-invasively from cell-free RNA in blood and urine. Building on research published in Nature and Nature Medicine, this talk covers the technology, the unmet clinical need, and Resero’s path to the clinic.
Clinical Dx Showcase:
Resero Bio
Resero Bio is a precision diagnostics company unlocking the cell-free transcriptome. Our proprietary liquid biopsy platform, RARE-seq, enables non-invasive cancer detection and provides real-time insight into dynamic gene expression and tumor biology.
Session Abstract – PMWC 2027 Silicon Valley
The PMWC 2027 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
